PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 189 filers reported holding PTC THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $210,654 | -59.2% | 9,400 | -26.0% | 0.00% | -60.0% |
Q2 2023 | $516,509 | +27.7% | 12,700 | +19.8% | 0.01% | +25.0% |
Q4 2022 | $404,602 | -32.8% | 10,600 | -11.7% | 0.00% | -42.9% |
Q3 2022 | $602,400 | +123.9% | 12,000 | +172.7% | 0.01% | +133.3% |
Q4 2020 | $269,000 | +10.2% | 4,400 | -8.3% | 0.00% | 0.0% |
Q2 2020 | $244,000 | -58.5% | 4,800 | -72.4% | 0.00% | -57.1% |
Q3 2019 | $588,000 | -27.9% | 17,400 | -3.9% | 0.01% | -22.2% |
Q2 2019 | $815,000 | +19.7% | 18,100 | 0.0% | 0.01% | +12.5% |
Q1 2019 | $681,000 | -3.7% | 18,100 | -12.1% | 0.01% | -20.0% |
Q4 2018 | $707,000 | -27.0% | 20,600 | 0.0% | 0.01% | -9.1% |
Q3 2018 | $968,000 | -40.5% | 20,600 | -57.3% | 0.01% | -45.0% |
Q2 2018 | $1,626,000 | +334.8% | 48,200 | +157.8% | 0.02% | +300.0% |
Q3 2017 | $374,000 | +11.0% | 18,700 | +1.6% | 0.01% | +25.0% |
Q2 2017 | $337,000 | +80.2% | 18,400 | -3.2% | 0.00% | +100.0% |
Q1 2017 | $187,000 | -19.0% | 19,000 | +400.0% | 0.00% | -33.3% |
Q1 2015 | $231,000 | – | 3,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
Chubb Ltd | 8,180 | $387,000 | 1.10% |